AstraZeneca PLC - Free Cash Flow To The Firm

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Free-Cash-Flow-To-The-Firm" stands at 10.31 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

AstraZeneca PLC's third quarter result of 3.57 Billion USD for the item "Free Cash Flow To The Firm" represents an increase of 113.16 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of 3.57 Billion USD for the item "Free Cash Flow To The Firm" represents an increase of 58.91 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of 10.31 Billion USD for the item "Free Cash Flow To The Firm" represents an increase of 14.74 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 35.61 percent compared to the value the year prior.
The 1 year change in percent is 35.61.
The 3 year change in percent is 52.21.
The 5 year change in percent is 235.47.
The 10 year change in percent is 273.29.

The Serie's long term average value is 4.74 Billion United States Dollars. It's latest available value, on 09/30/2025, is 117.50 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2018, to it's latest available value, on 09/30/2025, is +812.07%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.